• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
ZHANG Junlin,WANG Shaorong,WANG Shuhua.Introduction of common deficiencies and issues in CMC review of generic drugs[J].Journal Of Pharmaceutical Research,2024,43(10):972-978[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3071times   Download 2659次 QR Code for this article
Scan with your phone!
化学仿制药药学审评常见缺陷和共性问题简介
章俊麟,王少戎,王淑华
Font:Larger+|Default|Smaller-
(国家药品监督管理局药品审评中心,北京 100076)
摘要:
各国监管机构为提高仿制药审评质量和效率发布了一系列常见缺陷和共性问题,为规范和提升化学仿制药注册申报质量发挥了重要的作用。本文对中美欧等监管机构已发布的与提高申报资料质量相关的指导原则或技术性文件进行归纳总结,对其中与仿制药注册申报中药学技术审评相关的共性问题进行介绍,希望能对促进我国仿制药的高质量发展提供一隅之见。
关键词:  化学仿制药  常见缺陷和共性问题  高质量发展  药品审评
DOI:10.13506/j.cnki.jpr.2024.10.008
基金项目:
Publication Date:October 30, 2024
Introduction of common deficiencies and issues in CMC review of generic drugs
ZHANG Junlin,WANG Shaorong,WANG Shuhua
(Center for Drug Evaluation,National Medical Products Administration,Beijing 100076,China)
Abstract:
Regulatory agencies in various countries have issued a series of documents on common deficiencies and issues to improve the efficiency of generic drug review, which play an important role in standardizing and improving the quality of filing information. This paper intends to summarize the guidelines or technical documents that have been issued by FDA, EMA and NMPA related to the improvement of the quality of the declaration information, and introduce the common issues related to the pharmacy technical review of the generic drug declarations therein, in the hope that it can provide a glimpse of the high-quality development and reform of China's generic drugs.
Key words:  Generic Drugs  Common Deficiencies and Issues  High-Quality Development  Drug Review
Today's Visits:509    Total Visits:2383239
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.